title: Anti-leishmania infantum IgG antibody avidity in visceral leishmaniasis.
abstract: IgG avidity tests are used to discriminate acute from chronic infections. There are few reports on the IgG avidity profile of patients with visceral leishmaniasis (VL). This study investigated the anti-Leishmania IgG avidity in patients with classic VL (n = 10), patients showing clinical cure after treatment (n = 18), and asymptomatic subjects with at least one positive Leishmania test (n = 20). All subjects were from areas in Brazil where VL is endemic. Serum samples were collected from each subject on two different occasions. IgG avidity was evaluated by Western blotting. The proportion of high-avidity antibodies was higher in all samples from patients with classic VL. In contrast, low-avidity antibodies predominated in subjects with a history of VL, including 13 cases (72.2%) in the first assessment and 14 (77.8%) in the second. Fifteen (75%) of the asymptomatic subjects presented a predominance of low-avidity antibodies in the first assessment, and the frequency of high-avidity antibodies increased over time in seven subjects (35%) of this group. Antibodies against the 14- and/or 16-kDa antigen fraction were detected in the first assessment in all patients with classic VL, in 10 (55.5%) treated patients, and in 10 (50%) asymptomatic subjects. These were high-avidity antibodies in most cases. In the asymptomatic group, an increase in IgG avidity against the 14- and/or 16-kDa antigen fraction was observed in three cases (15%). The results indicate distinct responses in infected and asymptomatic subjects, probably associated with the length of time after infection. In this respect, IgG avidity tests represent a new approach to better characterize asymptomatic VL.
authors.affiliation: Department of Tropical Medicine and Infectology, Universidade Federal do Triângulo Mineiro, Uberaba, Brazil.
authors.forename: Monique Gomes Salles
authors.initials: MG
authors.lastname: Tiburcio
authors.forename: Laís
authors.initials: L
authors.lastname: Anversa
authors.forename: Kelly Aparecida
authors.initials: KA
authors.lastname: Kanunfre
authors.forename: Antonio Walter
authors.initials: AW
authors.lastname: Ferreira
authors.forename: Virmondes
authors.initials: V
authors.lastname: Rodrigues Júnior
authors.forename: Luciana de Almeida
authors.initials: Lde A
authors.lastname: Silva
mesh_terms: D000913:Antibodies, Protozoan / Q000097:blood*; D000915:Antibody Affinity; D000953:Antigens, Protozoan / Q000737:chemistry / Q000276:immunology; D058070:Asymptomatic Diseases; D015153:Blotting, Western; D001938:Brazil; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D018314:Leishmania infantum / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000276:immunology*; D008970:Molecular Weight
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D007074:Immunoglobulin G